Systematic evaluation of design features enables efficient selection of Π electron-stabilized polymeric micelles.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
30 Jun 2020
Historique:
received: 29 02 2020
revised: 03 05 2020
accepted: 04 05 2020
pubmed: 12 5 2020
medline: 4 3 2021
entrez: 12 5 2020
Statut: ppublish

Résumé

Polymeric micelles (PM) based on poly(ethylene glycol)-b-poly(N-2-benzoyloxypropyl methacrylamide) (mPEG-b-p(HPMA-Bz)) loaded with paclitaxel (PTX-PM) have shown promising results in overcoming the suboptimal efficacy/toxicity profile of paclitaxel. To get insight into the stability of PTX-PM formulations upon storage and to optimize their in vivo tumor-targeted drug delivery properties, we set out to identify a lead PTX-PM formulation with the optimal polymer composition. To this end, PM based on four different mPEG

Identifiants

pubmed: 32389790
pii: S0378-5173(20)30393-8
doi: 10.1016/j.ijpharm.2020.119409
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Drug Carriers 0
Methacrylates 0
Micelles 0
Polyethylene Glycols 3WJQ0SDW1A
Benzene J64922108F
Paclitaxel P88XT4IS4D
hydroxypropyl methacrylate UKW89XAX2X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119409

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Maryam Sheybanifard (M)

Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany.

Nataliia Beztsinna (N)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, 3508 TB Utrecht, the Netherlands.

Mahsa Bagheri (M)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, 3508 TB Utrecht, the Netherlands.

Eva Miriam Buhl (EM)

Electron Microscopy Facility, Institute of Pathology, RWTH University Hospital, Aachen, Germany.

Jaleesa Bresseleers (J)

ChemConnection BV - Ardena Oss, 5349 AB Oss, the Netherlands; Department of Bio-Organic Chemistry, Eindhoven University of Technology, 5600 MB Eindhoven, the Netherlands.

Aida Varela-Moreira (A)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, 3508 TB Utrecht, the Netherlands; Laboratory of Clinical Chemistry and Hematology (LKCH), University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.

Yang Shi (Y)

Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany.

Cornelus F van Nostrum (CF)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, 3508 TB Utrecht, the Netherlands.

Gabri van der Pluijm (G)

Leiden University Medical Center, Department of Urology, J-3-108, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.

Gert Storm (G)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, 3508 TB Utrecht, the Netherlands; Department of Biomaterials Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands.

Wim E Hennink (WE)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, 3508 TB Utrecht, the Netherlands.

Twan Lammers (T)

Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, 3508 TB Utrecht, the Netherlands; Department of Biomaterials Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands.

Josbert M Metselaar (JM)

Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany; Department of Biomaterials Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands. Electronic address: jmetselaar@ukaachen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH